Opportunity Information: Apply for RFA DC 19 002

This funding opportunity, RFA-DC-19-002, is a limited-competition cooperative agreement (U24; clinical trials not allowed) from the National Institutes of Health, specifically NIDCD (National Institute on Deafness and Other Communication Disorders). It supports the NIDCD National Temporal Bone, Hearing and Balance Pathology Resource Registry, a long-standing national research resource focused on human auditory (hearing) and vestibular (balance) science. The central idea is to sustain and strengthen a coordinated national system that tracks, manages, and helps make accessible human temporal bone specimens and related data so researchers can study the middle and inner ear in ways that are not possible in living people.

The Registry is described as more than a basic database or a simple tissue bank. Its mission combines several functions: coordinating the collection of temporal bone tissues after death, standardizing and recording specimen-related information, building and maintaining an information-rich data infrastructure, and actively recruiting people who are willing to pledge temporal bone donation. It also serves as a public-facing resource, including maintaining an up-to-date website that informs both the scientific community and the public about temporal bone donation and the availability and importance of these specimens for research. Because many critical ear disorders involve microscopic anatomy, cellular pathology, or molecular changes that cannot be examined directly in living humans, temporal bone specimens are uniquely valuable for answering questions about disease mechanisms, structure-function relationships, and the biological basis of hearing and balance disorders. The opportunity also emphasizes translation: human temporal bone research can validate and extend findings from animal models by confirming whether similar mechanisms and pathologies occur in humans.

A major expected outcome under this cooperative agreement is the continued development and maintenance of a growing national database that provides detailed, searchable information about both new and archival temporal bone tissues across the United States. This includes practical specimen-level details such as where tissues are located, their condition, and other bioinformatics-style descriptors that help investigators determine whether specific specimens are appropriate for particular research questions. The Registry is also expected to actively communicate with scientific and clinical researchers to disseminate information about available resources, helping investigators connect with appropriate specimen-holding laboratories and understand what materials and associated data exist.

Operationally, the opportunity calls for a well-organized nationwide network of on-call experts who can support timely post-mortem harvesting of temporal bone tissues. Temporal bone procurement is time-sensitive and technically demanding, so the Registry is expected to maintain readiness and coordination capacity so recoveries can occur quickly and appropriately when a donor passes away. In addition, applicants are expected to develop and implement strategies for the efficient receipt and transfer of harvested tissue to nearby temporal bone laboratories, which helps protect tissue quality and ensures that specimens enter established processing and storage pipelines with minimal delay.

The grant also encourages innovation and improvement in donor recruitment and post-mortem tissue procurement. That includes developing new methods or techniques that increase donor participation, streamline logistics, and improve overall specimen quality and usability for modern research needs. Another key element is linking pledges for donation with relevant medical histories, enabling future research that connects clinical symptoms and functional disorders (such as particular forms of hearing loss, tinnitus, or balance dysfunction) with morphological, biochemical, and genetic findings in the donated tissues. In practice, this means building the infrastructure and consent/communication processes needed to pair specimen information with meaningful clinical context, which significantly increases the scientific value of each donation.

Education and outreach are explicitly part of the program. The Registry is expected to provide outreach to researchers, clinicians, and the public to explain why temporal bone donations matter, how donation works, and how these specimens advance understanding and treatment of ear disorders. This public information role is reinforced by the requirement for an up-to-date website and ongoing communications about the Registry and its resources.

In terms of eligibility and restrictions, the opportunity is limited and U.S.-focused. Eligible applicants include public and state-controlled institutions of higher education. Foreign institutions are not eligible to apply, and non-U.S. components of U.S. organizations are also not eligible. Foreign components, as defined by the NIH Grants Policy Statement, are not allowed under this announcement. The funding instrument is a cooperative agreement, which typically means substantial NIH programmatic involvement compared to a standard grant, with NIH staff working collaboratively with the awardee on key goals, coordination, and oversight.

Key administrative details provided include an award ceiling of $425,000, an original closing date of June 24, 2019, and a creation date of July 5, 2018. The CFDA number listed is 93.173, and the activity category is Health. Overall, the opportunity is aimed at sustaining a national, coordinated, and service-oriented infrastructure that makes high-value human temporal bone specimens and associated data discoverable, obtainable, and scientifically useful, while strengthening donor recruitment, rapid procurement capacity, and outreach to both the research community and the public.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Limited Competition: NIDCD National Temporal Bone, Hearing and Balance Pathology Resource Registry (U24 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.173.
  • This funding opportunity was created on 2018-07-05.
  • Applicants must submit their applications by 2019-06-24. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $425,000.00 in funding.
  • Eligible applicants include: Public and State controlled institutions of higher education.
Apply for RFA DC 19 002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional)

Previous opportunity: Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01 Clinical Trial Optional)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DC 19 002

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DC 19 002) also looked into and applied for these:

Funding Opportunity
Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1 Clinical Trial Required) Apply for RFA AI 18 036

Funding Number: RFA AI 18 036
Agency: National Institutes of Health
Category: Health
Funding Amount: $10,000,000
Encouraging Development of Novel Amelogenesis Models (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA DE 19 004

Funding Number: RFA DE 19 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Cooperative Agreement to Support Navigators in Federally-facilitated Exchanges Apply for CA NAV 18 001

Funding Number: CA NAV 18 001
Agency: CMS-Consumer Information Insurance Oversight
Category: Health
Funding Amount: Case Dependent
Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed) Apply for PA 18 859

Funding Number: PA 18 859
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Advancing Research Needed to Develop a Universal Influenza Vaccine (R21 Clinical Trial Not Allowed) Apply for PA 18 858

Funding Number: PA 18 858
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required) Apply for RFA HL 19 025

Funding Number: RFA HL 19 025
Agency: National Institutes of Health
Category: Health
Funding Amount: $150,000
NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed) Apply for PAR 18 864

Funding Number: PAR 18 864
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Immune Response to Arthropod Blood Feeding (R21 Clinical Trial Not Allowed) Apply for PAR 18 860

Funding Number: PAR 18 860
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed) Apply for RFA HL 19 026

Funding Number: RFA HL 19 026
Agency: National Institutes of Health
Category: Health
Funding Amount: $150,000
Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed) Apply for PAR 18 865

Funding Number: PAR 18 865
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research Innovations for Scientific Knowledge (RISK) for Musculoskeletal Diseases (R61/R33 Clinical Trial Not Allowed) Apply for RFA AR 19 013

Funding Number: RFA AR 19 013
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) Apply for RFA RM 18 021

Funding Number: RFA RM 18 021
Agency: National Institutes of Health
Category: Health
Funding Amount: $100,000
Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (X02 Clinical Trial Not Allowed) Apply for PAR 18 866

Funding Number: PAR 18 866
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed) Apply for RFA RM 18 030

Funding Number: RFA RM 18 030
Agency: National Institutes of Health
Category: Health
Funding Amount: $8,000,000
Novel Approaches for Relating Genetic Variation to Function and Disease (R21 Clinical Trial Not Allowed) Apply for PA 18 867

Funding Number: PA 18 867
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed) Apply for PA 18 868

Funding Number: PA 18 868
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research Innovations for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (R61/R33 Clinical Trial Not Allowed) Apply for RFA AR 19 012

Funding Number: RFA AR 19 012
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Research to Advance Vaccine Safety (R01 Clinical Trial Not Allowed) Apply for PA 18 873

Funding Number: PA 18 873
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01 Clinical Trial Not Allowed) Apply for RFA AI 18 029

Funding Number: RFA AI 18 029
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Research to Advance Vaccine Safety (R21 Clinical Trial Not Allowed) Apply for PA 18 872

Funding Number: PA 18 872
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DC 19 002", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: